Post
of 273,509
$BVAXF $BIOV Not Your Typical Early-Stage Biotech. It’s a platform-first, licensing-focused company built on decades of prior science
https://www.instagram.com/reel/DS2WTkijoS9/
~ 120+ Patents
~ $300 Million Historical R&D
~ .14 Stock Price
~ Only $6 Million Market Cap
https://www.instagram.com/reel/DS2WTkijoS9/
~ 120+ Patents
~ $300 Million Historical R&D
~ .14 Stock Price
~ Only $6 Million Market Cap